Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.50
Bid: 61.00
Ask: 64.00
Change: 0.00 (0.00%)
Spread: 3.00 (4.918%)
Open: 62.50
High: 62.50
Low: 62.50
Prev. Close: 62.50
PCIP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 May 2017 07:00

RNS Number : 9737D
PCI-PAL PLC
03 May 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

PCI-PAL PLC

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation: iii

Peter Wildey

4. Full name of shareholder(s)

(if different from 3.): iv

5. Date of the transaction and date on which the threshold is crossed or reached: v

26th & 27th April 2017

6. Date on which issuer notified:

27th April 2017

7. Threshold(s) that is/are crossed or

reached: vi, vii

16%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0009737155

5,136,000

5,136,000

4,926,000

4,926,000

15.61%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/ConversionPeriod xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exerciseprice

Expirationdate xvii

Exercise/Conversionperiod xviii

Number of votingrights instrumentrefers to

% of voting rights xix, xx

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 4,926,000

 15.61%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

14. Contact name:

 William Good

15. Contact telephone number:

 0330 131 0345

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLOKBDQCBKDKPK
Date   Source Headline
17th Apr 20245:45 pmRNSHolding(s) in Company
8th Apr 202410:28 amRNSIssue of Equity & TVR
5th Apr 20247:00 amRNSIssue of Options & Director Share Purchases
4th Apr 202410:24 amRNSIssue of Equity & TVR
28th Mar 20246:15 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSExercise of Options, Director/PCA Dealings & TVR
26th Mar 202410:57 amRNSPDMR Issue of Options
12th Mar 202412:55 pmRNSResult of Oversubscribed Placing & TVR
12th Mar 20247:00 amRNSProposed Placing to raise up to £3.5m
27th Feb 20247:00 amRNSInterim Results, Board Change & Presentations
20th Feb 20247:00 amRNSNotice of Results, Analyst & Investor Presentation
6th Feb 20247:00 amRNSTrading Update & Notice of Results
26th Jan 202412:50 pmRNSUK Patent Case Update
22nd Jan 20244:59 pmRNSHolding(s) in Company
15th Jan 202412:20 pmRNSIssue of Equity
20th Dec 20237:00 amRNSSuccessful Completion of Form of Order Hearing
19th Dec 20237:00 amRNSUK Court Hearing
12th Dec 20231:40 pmRNSResult of AGM
12th Dec 20237:00 amRNSAGM Statement
24th Nov 202310:45 amRNSAnnual Financial Report & Notice of AGM
13th Nov 20237:00 amRNSNew strategic reseller partnership with Zoom
9th Nov 20237:00 amRNSFinal Results, Analyst Briefing & Investor Pres
6th Nov 20237:00 amRNSNotice of Results Analyst Briefing & Investor Pres
5th Oct 202311:49 amRNSIssue of Equity
4th Oct 20235:13 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSDetail on Patent Case Outcome & Trading Update
25th Sep 20235:29 pmRNSTotal Victory for PCI Pal in UK High Court
4th Sep 20237:00 amRNSHolding(s) in Company
26th Jun 202311:33 amRNSHolding(s) in Company
7th Jun 20237:00 amRNSBreach of confidentiality agreement by Sycurio Ltd
30th May 20237:00 amRNSDirector/PDMR Share Purchase
25th May 202311:08 amRNSDirector/PDMR Share Purchase
24th May 20237:00 amRNSTrading and Patent Case Updates
14th Mar 20237:00 amRNSInterim Results, Analyst Briefing & Investor Pres
13th Mar 20237:49 amRNSSVB Update
28th Feb 20237:00 amRNSNotice of Results, Analyst Call & Investor Pres
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
27th Oct 202212:32 pmRNSResult of AGM
27th Oct 20227:00 amRNSAGM Statement
20th Oct 20227:00 amRNSPDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Issue of Options
6th Oct 20223:13 pmRNSDirector/PDMR share purchase
4th Oct 202210:37 amRNSAnnual Financial Report & Notice of AGM
22nd Sep 20227:00 amRNSPCI Pal launches open banking payments product
6th Sep 20227:00 amRNSFinal Results, Analyst Briefing & Investor Pres
16th Aug 20227:00 amRNSNotice of Results Analyst Briefing & Investor Pres
27th Jul 20227:00 amRNSTrading Update & Notice of Results
1st Jul 20227:00 amRNSDirectorate Change
30th Jun 20221:56 pmRNSIssue of Equity
28th Jun 20227:00 amRNSUpdate on Patent Infringement Claims

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.